PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE

Podobné jednotky

• A MULTI-CENTER RANDOMIZED TRIAL OF BUPRENORPHINE-NALOXONE VERSUS CLONIDINE FOR OPIOID DETOXIFICATION: FINDINGS FROM THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK
  Autor: LING, W.
  Vydáno: (2005)
• BUPRENORPHINE MAINTENANCE TREATMENT OF OPIATE DEPENDENCE: A MULTICENTER, RANDOMIZED CLINICAL TRIAL
  Autor: LING, W.
  Vydáno: (1998)
• Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
  Autor: Hser, Y.I
  Vydáno: (2014)
• A RANDOMIZED CONTROLLED TRIAL OF BUPRENORPHINE IN THE MANAGEMENT OF SHORT-TERM AMBULATORY HEROIN WITHDRAWAL
  Autor: LINTZERIS, N.
  Vydáno: (2002)
• PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY
  Autor: CHAKRABARTI, A.
  Vydáno: (2010)